FIELD: drugs, medicine.
SUBSTANCE: invention relates to application of 1-methylindolyl-3-thioacetic acid tris-(2-hydroxyethyl)ammonia salt, which is known hypolipidemic agent, as immunosuppressor. Present invention ales it possible to produce pharmaceuticals for transplanted organ and tissue rejection prophylaxis or treatment of various immune-associated diseases.
EFFECT: new drug for transplant rejection prophylaxis or treatment of immune-associated diseases.
3 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| IMMUNOMODULATING AGENT | 2003 |
|
RU2224513C1 |
| IMMUNOMODULATOR | 2003 |
|
RU2252757C1 |
| IMMUNOMODULATOR | 2003 |
|
RU2253444C1 |
| IMMUNOMODULATING AGENT | 2003 |
|
RU2245142C1 |
| IMMUNOMODULATING AGENT | 2003 |
|
RU2240794C1 |
| IMMUNODEPRESSANT | 2002 |
|
RU2228178C1 |
| IMMUNOMODULATING AGENT | 2003 |
|
RU2224512C1 |
| IMMUNOMODULATOR | 2003 |
|
RU2253447C1 |
| METHOD FOR TREATING AUTOIMMUNE DISEASES | 2003 |
|
RU2252760C1 |
| IMMUNOMODULATOR | 2003 |
|
RU2253445C1 |
